Hormel Foods to Sell Whole-Bird Turkey Segment by Q2 Fiscal 2026 to Life-Science Innovations
Hormel Foods agreed to sell its whole-bird turkey business—including the Melrose production facility, Swanville feed mill and transport assets—to Life-Science Innovations, with closing expected by end of Q2 fiscal 2026. The buyer will assume grower contracts and provide co-manufacturing through FY2026, with Hormel forecasting low impact on adjusted 2026 results.
1. Agreement Overview
Hormel Foods has entered into an agreement to divest its whole-bird turkey business to Life-Science Innovations. The transaction is slated to close by the end of the company’s second quarter of fiscal 2026, and Jennie-O branded products and naming rights remain with Hormel Foods.
2. Assets and Operations Included
The sale transfers the Melrose, Minnesota whole-bird production facility, the Swanville feed mill and related transportation assets. Life-Science Innovations will also assume supply contracts with third-party turkey growers and deliver co-manufacturing services to Hormel Foods through the end of fiscal 2026.
3. Strategic Rationale and Financial Impact
This divestiture aligns with Hormel Foods’ strategy to expand its value-added protein portfolio while reducing exposure to commodity-driven segments. Hormel Foods expects the transaction to have a minimal impact on its adjusted fiscal 2026 results, with detailed guidance to be provided during its upcoming quarterly earnings call.
4. Buyer Expertise and Relationship
Life-Science Innovations, based in Willmar, Minnesota, brings expertise across turkey genetics, hatching and processing. The agreement continues a 75-year partnership with the Jennie-O business and leverages the buyer’s state-of-the-art hatchery and hen supply network.